文章摘要

奥希替尼治疗 EGFR 突变晚期非小细胞肺癌有效性的系统评价再评价的初步分析

作者: 1米雪, 2苏小红, 3朱亚宁, 3曹璐, 3左燕, 3郭振军, 4高华
1 宁夏医科大学药学院，银川 750000
2 宁夏医科大学总医院院内感染科，银川 750000
3 陕西省人民医院药学 部，西安 710032
4 宁夏医科大学总医院药剂科，银川 750000
通讯: 高华 Email: gaohualike@163.com
DOI: 10.3978/j.issn.2095-6959.

摘要

/
关键词：

The overview of systematic reviews of osimertinib in the treatment for advanced non-small cell lung cancer with EGFR mutation’s efficacy: preliminary analysis

Authors: 1MI Xue, 2SU Xiaohong, 3ZHU Yaning, 3GUO Zhenjun, 3CAO Lu, 3ZUO Yan, 4GAO Hua
1 Department of Pharmacy, Ningxia Medical University, Yinchuan 750000, China
2 Department of Nosocomial Infection, General hospital of Ningxia Medical University, Yinchuan 750000, China
3 Department of Pharmacy, Shanxi Provincial People’s Hospital, Xi’an 710032, China
4 Department of Pharmacy, General hospital of Ningxia Medical University, Yinchuan 750000, China

CorrespondingAuthor: GAO Hua Email: gaohualike@163.com

DOI: 10.3978/j.issn.2095-6959.

Abstract

/